Biosimilars versus Generics Research Assignment Paper (Essay Sample)

Bio – similar Versus Generics
Student name
University
Bio-similars versus Generics
Bio-similars are versions of original biologics but comparably cheaper than the original biologics. They are preferred as the alternatives due to the rising costs of the originals. Since the demand for less costly is on the rise, the market and demand for bio-similars keeps on rising but unfortunately, it cannot move speedily because of several hindering factors. This article shows that companies that have tried to invade the market by introducing bio-similars in the U.S are already facing legal hurdles (Anna Journal Editor, 2016).
Distinguishing biosimilars and biologics is complicated but, as the introduction of bio-similars into the market faces the legal challenges, we can understand the underlying facts about the bio-similars and this will help establish answers about the biologics and bio-similars.
Bio-similar Drugs: The Promise of Great Science and Great Pricing
Manufactured to counteract different diseases, bio-similar scientifically manufactured and programmed. They are different from other traditional drugs because there target is the causes of the disease rather than treating the symptoms. The bio-similar has been in existence long enough, in fact, they have been around for 33 years, and their progression not halted or reversed (Ginsberg Journal Editor, 2016). It is something similar to biologics and not identical because of their complexity as living cells and this explains why it is hard to copy exactly the pills to resemble biologics.
Effect of Biosimilar products on health care delivery
The invasion of bio-similar in the market will have a great effect on health care delivery. First, they are comparatively cheap and affordable, they are found easily as compared to biologics that are less predominant in the markets. Due to their cost-effectiveness, many people prefer bio-similar to biologics. The need for health care services is on the rise, many diseases are affecting people and population increases day by day. This calls production of more affordable drugs that will meet these challenges. The manufacture of biologics requires a deep scientific research and huge investments in the technology. This squeezes the scope of production and it becomes to meet the rising high market demands.
An alternative, bio-similar drug try to bridge this gap by making it easy for the middle class to afford the health care services. It is worth noting that these drugs are available in the local chemists as well as those high- class chemists. This enables many people to access them with a lot of ease. Easy and quick accessibility of health care is a factor, that is paramount and in any case, something to do with health care is accessible to many, then it is worth appreciating.
Effect of change of Government policy on bio-similar
The government tries to regulate the escalation of bio- similar drugs to prevent cases of poor quality and pricing in the market. The integrity of manufacturing companies that produce biologics need to be up-held; their brand names are not stolen. The government policy on this makes it hard for fake manufacturers to invade the market and pour in their low quality products. The question now arises, how does this affect the growth of bio-similars? Though the trend regulated, but the bio-similars help many people afford drugs and find them easily, if the government becomes too hard and strict and does not encourage it, then many people are will not access proper health care.
The government...